Salarius Pharmaceuticals Files 8-K
Ticker: DCOY · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1615219
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
Salarius Pharma filed an 8-K on 7/14, reporting events as of 7/10. Standard filing.
AI Summary
Salarius Pharmaceuticals, Inc. filed an 8-K on July 14, 2025, reporting other events and financial statements as of July 10, 2025. The company, formerly known as Flex Pharma, Inc., is based in Houston, TX, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing indicates ongoing corporate reporting and potential updates regarding Salarius Pharmaceuticals' financial status or other material events.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting standard corporate events and financial statements, not indicating immediate significant risk.
Key Numbers
- 001-36812 — SEC File Number (Identifies the company's filing with the SEC)
- 46-5087339 — IRS Employer Identification Number (Company's tax identification number)
Key Players & Entities
- Salarius Pharmaceuticals, Inc. (company) — Registrant
- Flex Pharma, Inc. (company) — Former company name
- July 10, 2025 (date) — Date of earliest event reported
- July 14, 2025 (date) — Date of report
- 2450 Holcombe Blvd. Suite X Houston, TX 77021 (address) — Principal executive offices
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
What is the significance of the 'Financial Statements and Exhibits' being reported?
This indicates that the filing includes updated financial information and supporting documents for Salarius Pharmaceuticals, Inc.
When was Salarius Pharmaceuticals, Inc. formerly known as Flex Pharma, Inc.?
The date of the name change from Flex Pharma, Inc. to Salarius Pharmaceuticals, Inc. was July 30, 2014.
What is the primary business of Salarius Pharmaceuticals, Inc.?
Salarius Pharmaceuticals, Inc. operates in the 'Pharmaceutical Preparations' industry, with SIC code 2834.
What is the principal executive office address for Salarius Pharmaceuticals, Inc.?
The principal executive offices are located at 2450 Holcombe Blvd. Suite X, Houston, TX 77021.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding Salarius Pharmaceuticals, Inc. (DCOY).